Tapahtumakalenteri

 

This time we will hear about the latest developments in Adoptive Cell Therapies. This time we will hear about the latest developments in Adoptive Cell Therapies. We have the honor of hosting Boris Engels; Associate Director of the Novartis Institutes for Biomedical Research (Cambridge, USA), Dr. Sirpa Leppä (Physician in charge of the ward, Clinical Trial Unit of the Helsinki University Hospital and Professor at the University of Helsinki) and Dr. Anil Thorakura, Head of Immuno-Oncology at Orion Oy. In the panel discussion, we address opportunities and hurdles of taking adoptive cell therapies from bench to bedside.

 

Program:

15:00-15:10 Introduction. Dr. Anil Thotakura, Orion Pharmaceuticals

15:10-15:20 Clinical trials with CAR-T therapies. Prof. Sirpa Leppä, Helsinki University Hospital

15:20-16:10 Keynote (Title TBA). Dr. Boris Engels, Associate Director of the Novartis Institutes for Biomedical Research, Cambridge, USA

16:10-16:45 Panel: Opportunities and hurdles with clinical implementation of adoptive cell therapy.

Panelists: Boris Engels, Sirpa Leppä, Anil Thotakura, Matti Korhonen (Finnish Red Cross Blood Services)

 

Session Chair: Prof. Juha Klefström, Cancer IO